It is reported that more than 65% of non-muscle invasive bladder cancer (NMIBC) carry FGFR3 mutations.(1) A large study evaluated 10,032 bladder cancer and identified 56 different FGFR3 mutations.(2). This evidence concerns the gene FGFR3 and urinary bladder carcinoma.